SGMT

Sagimet Biosciences Inc. Series A Common Stock (SGMT)

US
$ 3.150.96%

Price Chart

Key Statistics

Market Cap
$ 280.1M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
467.94K
52W High
$ 10.43
52W Low
$ 1.73
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
4.4735
200-Day MA
4.3663
52 Week High
10.425
52 Week Low
1.73

About SGMT

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctio.

Employees
14
Headquarters
San Mateo, CA
CEO
Mr. David A. Happel

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
NKE
Nike Inc. Common St...
$ 72.10
15.25
SNAP
Snap Inc. Class A C...
$ 8.70
6.88
HIMS
Hims & Hers Health ...
$ 49.36
6.66
BA
Boeing Company (The...
$ 214.20
5.77
CCL
Carnival Corporatio...
$ 27.28
4.16

Top Losers

Symbol/Name
LTP
% Chg
QS
QuantumScape Corpor...
$ 6.62
-13.46
GPMT
Granite Point Mortg...
$ 2.46
-6.11
AEM
Agnico Eagle Mines ...
$ 116.00
-5.73
UAVS
AgEagle Aerial Syst...
$ 1.08
-5.26
PAAS
Pan American Silver...
$ 27.66
-5.05